Loading…
Multi-Pharmaceutical Activities of Chinese Herbal Polysaccharides in the Treatment of Pulmonary Fibrosis: Concept and Future Prospects
Pulmonary fibrosis is a fatal chronic progressive respiratory disease, characterized by continuous scarring of the lung parenchyma, leading to respiratory failure and death. The incidence of PF has increased over time. There are drugs, yet, there are some limitations. Hence, it is of importance to f...
Saved in:
Published in: | Frontiers in pharmacology 2021-08, Vol.12, p.707491-707491 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c442t-d842e2afdf1767a1761c808c4b6161b2fc0aeac6e88e37d95dfb2e70cc7579e3 |
---|---|
cites | cdi_FETCH-LOGICAL-c442t-d842e2afdf1767a1761c808c4b6161b2fc0aeac6e88e37d95dfb2e70cc7579e3 |
container_end_page | 707491 |
container_issue | |
container_start_page | 707491 |
container_title | Frontiers in pharmacology |
container_volume | 12 |
creator | Wu, Xianbo Huang, Jianli Wang, Jie Xu, Yihua Yang, Xinwei Sun, Minghan Shi, Jianyou |
description | Pulmonary fibrosis is a fatal chronic progressive respiratory disease, characterized by continuous scarring of the lung parenchyma, leading to respiratory failure and death. The incidence of PF has increased over time. There are drugs, yet, there are some limitations. Hence, it is of importance to find new therapies and new drugs to replace the treatment of pulmonary fibrosis. In recent years, there have been a great number of research reports on the treatment of traditional Chinese medicine polysaccharides in various system fields. Among them, the treatment of PF has also gained extensive attention. This review summarized the source of polysaccharides, the drug activity of traditional Chinese medicine, and the protective effects on targets of Pulmonary fibrosis. We hope it can inspire researchers to design and develop polysaccharides, serving as a reference for potential clinical therapeutic drugs. |
doi_str_mv | 10.3389/fphar.2021.707491 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_62db3c08b0744db79253fda703cbc838</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_62db3c08b0744db79253fda703cbc838</doaj_id><sourcerecordid>2570114417</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-d842e2afdf1767a1761c808c4b6161b2fc0aeac6e88e37d95dfb2e70cc7579e3</originalsourceid><addsrcrecordid>eNpVks9u3CAQxq2qVROleYDeOPbiLf_W4B4qRatuEylR97B3hIdxlsg2LuBIeYE8d9lsVCUcYMQ38wOGr6q-MroSQrff-_lg44pTzlaKKtmyD9U5axpRt5rxj2_is-oypQdahmhb0cjP1ZmQUreK0vPq-W4Zsq93hTVawCV7sAO5guwfffaYSOjJ5uAnTEiuMXZF3IXhKVmAUuJdyfATyQck-4g2jzjlY8luGcYw2fhEtr6LIfn0g2zCBDhnYidHtkteIpJdkWaEnL5Un3o7JLx8XS-q_fbXfnNd3_75fbO5uq1BSp5rpyVHbnvXM9UoWyYGmmqQXcMa1vEeqEULDWqNQrl27fqOo6IAaq1aFBfVzQnrgn0wc_RjuaIJ1puXjRDvjY2lBQOahrtOANVd6a10nWr5WvTOKiqgAy10Yf08sealG9FBeXm0wzvoe2XyB3MfHo2WrPwKL4Bvr4AY_i6Yshl9AhwGO2FYkuFrRRmTkqmSyk6pUBqWIvb_j2HUHN1gXtxgjm4wJzeIf5NBqzA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2570114417</pqid></control><display><type>article</type><title>Multi-Pharmaceutical Activities of Chinese Herbal Polysaccharides in the Treatment of Pulmonary Fibrosis: Concept and Future Prospects</title><source>PubMed Central</source><creator>Wu, Xianbo ; Huang, Jianli ; Wang, Jie ; Xu, Yihua ; Yang, Xinwei ; Sun, Minghan ; Shi, Jianyou</creator><creatorcontrib>Wu, Xianbo ; Huang, Jianli ; Wang, Jie ; Xu, Yihua ; Yang, Xinwei ; Sun, Minghan ; Shi, Jianyou</creatorcontrib><description>Pulmonary fibrosis is a fatal chronic progressive respiratory disease, characterized by continuous scarring of the lung parenchyma, leading to respiratory failure and death. The incidence of PF has increased over time. There are drugs, yet, there are some limitations. Hence, it is of importance to find new therapies and new drugs to replace the treatment of pulmonary fibrosis. In recent years, there have been a great number of research reports on the treatment of traditional Chinese medicine polysaccharides in various system fields. Among them, the treatment of PF has also gained extensive attention. This review summarized the source of polysaccharides, the drug activity of traditional Chinese medicine, and the protective effects on targets of Pulmonary fibrosis. We hope it can inspire researchers to design and develop polysaccharides, serving as a reference for potential clinical therapeutic drugs.</description><identifier>ISSN: 1663-9812</identifier><identifier>EISSN: 1663-9812</identifier><identifier>DOI: 10.3389/fphar.2021.707491</identifier><identifier>PMID: 34489700</identifier><language>eng</language><publisher>Frontiers Media S.A</publisher><subject>collagen-1 ; extracellular matrix ; Pharmacology ; polysaccharide ; pulmonary fibrosis ; traditional Chinese medicine ; transforming growth factor-β</subject><ispartof>Frontiers in pharmacology, 2021-08, Vol.12, p.707491-707491</ispartof><rights>Copyright © 2021 Wu, Huang, Wang, Xu, Yang, Sun and Shi. 2021 Wu, Huang, Wang, Xu, Yang, Sun and Shi</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-d842e2afdf1767a1761c808c4b6161b2fc0aeac6e88e37d95dfb2e70cc7579e3</citedby><cites>FETCH-LOGICAL-c442t-d842e2afdf1767a1761c808c4b6161b2fc0aeac6e88e37d95dfb2e70cc7579e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418122/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418122/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Wu, Xianbo</creatorcontrib><creatorcontrib>Huang, Jianli</creatorcontrib><creatorcontrib>Wang, Jie</creatorcontrib><creatorcontrib>Xu, Yihua</creatorcontrib><creatorcontrib>Yang, Xinwei</creatorcontrib><creatorcontrib>Sun, Minghan</creatorcontrib><creatorcontrib>Shi, Jianyou</creatorcontrib><title>Multi-Pharmaceutical Activities of Chinese Herbal Polysaccharides in the Treatment of Pulmonary Fibrosis: Concept and Future Prospects</title><title>Frontiers in pharmacology</title><description>Pulmonary fibrosis is a fatal chronic progressive respiratory disease, characterized by continuous scarring of the lung parenchyma, leading to respiratory failure and death. The incidence of PF has increased over time. There are drugs, yet, there are some limitations. Hence, it is of importance to find new therapies and new drugs to replace the treatment of pulmonary fibrosis. In recent years, there have been a great number of research reports on the treatment of traditional Chinese medicine polysaccharides in various system fields. Among them, the treatment of PF has also gained extensive attention. This review summarized the source of polysaccharides, the drug activity of traditional Chinese medicine, and the protective effects on targets of Pulmonary fibrosis. We hope it can inspire researchers to design and develop polysaccharides, serving as a reference for potential clinical therapeutic drugs.</description><subject>collagen-1</subject><subject>extracellular matrix</subject><subject>Pharmacology</subject><subject>polysaccharide</subject><subject>pulmonary fibrosis</subject><subject>traditional Chinese medicine</subject><subject>transforming growth factor-β</subject><issn>1663-9812</issn><issn>1663-9812</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVks9u3CAQxq2qVROleYDeOPbiLf_W4B4qRatuEylR97B3hIdxlsg2LuBIeYE8d9lsVCUcYMQ38wOGr6q-MroSQrff-_lg44pTzlaKKtmyD9U5axpRt5rxj2_is-oypQdahmhb0cjP1ZmQUreK0vPq-W4Zsq93hTVawCV7sAO5guwfffaYSOjJ5uAnTEiuMXZF3IXhKVmAUuJdyfATyQck-4g2jzjlY8luGcYw2fhEtr6LIfn0g2zCBDhnYidHtkteIpJdkWaEnL5Un3o7JLx8XS-q_fbXfnNd3_75fbO5uq1BSp5rpyVHbnvXM9UoWyYGmmqQXcMa1vEeqEULDWqNQrl27fqOo6IAaq1aFBfVzQnrgn0wc_RjuaIJ1puXjRDvjY2lBQOahrtOANVd6a10nWr5WvTOKiqgAy10Yf08sealG9FBeXm0wzvoe2XyB3MfHo2WrPwKL4Bvr4AY_i6Yshl9AhwGO2FYkuFrRRmTkqmSyk6pUBqWIvb_j2HUHN1gXtxgjm4wJzeIf5NBqzA</recordid><startdate>20210817</startdate><enddate>20210817</enddate><creator>Wu, Xianbo</creator><creator>Huang, Jianli</creator><creator>Wang, Jie</creator><creator>Xu, Yihua</creator><creator>Yang, Xinwei</creator><creator>Sun, Minghan</creator><creator>Shi, Jianyou</creator><general>Frontiers Media S.A</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20210817</creationdate><title>Multi-Pharmaceutical Activities of Chinese Herbal Polysaccharides in the Treatment of Pulmonary Fibrosis: Concept and Future Prospects</title><author>Wu, Xianbo ; Huang, Jianli ; Wang, Jie ; Xu, Yihua ; Yang, Xinwei ; Sun, Minghan ; Shi, Jianyou</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-d842e2afdf1767a1761c808c4b6161b2fc0aeac6e88e37d95dfb2e70cc7579e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>collagen-1</topic><topic>extracellular matrix</topic><topic>Pharmacology</topic><topic>polysaccharide</topic><topic>pulmonary fibrosis</topic><topic>traditional Chinese medicine</topic><topic>transforming growth factor-β</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wu, Xianbo</creatorcontrib><creatorcontrib>Huang, Jianli</creatorcontrib><creatorcontrib>Wang, Jie</creatorcontrib><creatorcontrib>Xu, Yihua</creatorcontrib><creatorcontrib>Yang, Xinwei</creatorcontrib><creatorcontrib>Sun, Minghan</creatorcontrib><creatorcontrib>Shi, Jianyou</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Frontiers in pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wu, Xianbo</au><au>Huang, Jianli</au><au>Wang, Jie</au><au>Xu, Yihua</au><au>Yang, Xinwei</au><au>Sun, Minghan</au><au>Shi, Jianyou</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multi-Pharmaceutical Activities of Chinese Herbal Polysaccharides in the Treatment of Pulmonary Fibrosis: Concept and Future Prospects</atitle><jtitle>Frontiers in pharmacology</jtitle><date>2021-08-17</date><risdate>2021</risdate><volume>12</volume><spage>707491</spage><epage>707491</epage><pages>707491-707491</pages><issn>1663-9812</issn><eissn>1663-9812</eissn><abstract>Pulmonary fibrosis is a fatal chronic progressive respiratory disease, characterized by continuous scarring of the lung parenchyma, leading to respiratory failure and death. The incidence of PF has increased over time. There are drugs, yet, there are some limitations. Hence, it is of importance to find new therapies and new drugs to replace the treatment of pulmonary fibrosis. In recent years, there have been a great number of research reports on the treatment of traditional Chinese medicine polysaccharides in various system fields. Among them, the treatment of PF has also gained extensive attention. This review summarized the source of polysaccharides, the drug activity of traditional Chinese medicine, and the protective effects on targets of Pulmonary fibrosis. We hope it can inspire researchers to design and develop polysaccharides, serving as a reference for potential clinical therapeutic drugs.</abstract><pub>Frontiers Media S.A</pub><pmid>34489700</pmid><doi>10.3389/fphar.2021.707491</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1663-9812 |
ispartof | Frontiers in pharmacology, 2021-08, Vol.12, p.707491-707491 |
issn | 1663-9812 1663-9812 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_62db3c08b0744db79253fda703cbc838 |
source | PubMed Central |
subjects | collagen-1 extracellular matrix Pharmacology polysaccharide pulmonary fibrosis traditional Chinese medicine transforming growth factor-β |
title | Multi-Pharmaceutical Activities of Chinese Herbal Polysaccharides in the Treatment of Pulmonary Fibrosis: Concept and Future Prospects |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T17%3A38%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multi-Pharmaceutical%20Activities%20of%20Chinese%20Herbal%20Polysaccharides%20in%20the%20Treatment%20of%20Pulmonary%20Fibrosis:%20Concept%20and%20Future%20Prospects&rft.jtitle=Frontiers%20in%20pharmacology&rft.au=Wu,%20Xianbo&rft.date=2021-08-17&rft.volume=12&rft.spage=707491&rft.epage=707491&rft.pages=707491-707491&rft.issn=1663-9812&rft.eissn=1663-9812&rft_id=info:doi/10.3389/fphar.2021.707491&rft_dat=%3Cproquest_doaj_%3E2570114417%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c442t-d842e2afdf1767a1761c808c4b6161b2fc0aeac6e88e37d95dfb2e70cc7579e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2570114417&rft_id=info:pmid/34489700&rfr_iscdi=true |